RecruitingNot ApplicableNCT05512234

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

A Double-blind, Mylti-center, Randomised, Placebo-controlled, Parallel-group Study Evaluating the Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic


Sponsor

BioGaia AB

Enrollment

102 participants

Start Date

Jul 13, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a double-blind, multi-center, randomized, placebo-controlled, parallel-group study in infants with colic with the primary objective to evaluate crying time.


Eligibility

Min Age: 3 WeeksMax Age: 8 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying L. reuteri and Placebo for people with colic, infantile. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 3 Weeks to 8 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTL. reuteri

Dietary supplementation with drops containing L. reuteri once daily for 21 consecutive days

DIETARY_SUPPLEMENTPlacebo

Dietary supplementation with placebo drops identical to those containing L. reuteri once daily for 21 consecutive days


Locations(2)

Atlantia Clinical Trials

Cork, Ireland

Clinical Trail Consultants AB

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05512234


Related Trials